Nektar Therapeutics (0UNL.LSE) Q1 2025 Earnings

Mar 12Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.25
-0.16
-0.06
0.03

Details

Expected EPS
-0.13561
Actual EPS
0.03
Surprise EPS
0.17
Surprise Percent
+122.12%

Description

⁨Nektar Therapeutics⁩ (⁦0UNL.LSE⁩) has reported earnings of ⁦0.03⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts